^Bradi?, I; Pasini, M (1975). “Hirschsprung's disease -- therapy and results”. Acta chirurgica Iugoslavica22 (2): 183-95. PMID1235738.
^Boonen, Georg; Haberlein, Hans (2007). “Influence of Genuine Kavapyrone Enantiomers on the GABAABinding Site”. Planta Medica64 (6): 504-6. doi:10.1055/s-2006-957502. PMID9776662.
^Grunze, Heinz; Langosch, Jens; Schirrmacher, Karin; Bingmann, Dieter; Von Wegerer, Jorg; Walden, Jorg (2001). “Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers - a review”. Progress in Neuro-Psychopharmacology and Biological Psychiatry25 (8): 1555-70. doi:10.1016/S0278-5846(01)00208-1. PMID11642654.
^Rowe, A.; Narlawar, R.; w. Groundwater, P.; Ramzan, I. (2011). “Kavalactone Pharmacophores for Major Cellular Drug Targets”. Mini Reviews in Medicinal Chemistry11 (1): 79-83. doi:10.2174/138955711793564088. PMID21034404.